Co-GP / Platform:A family office could deploy into the Greater Boston life science market by backing a sponsor or operator at the GP level to share in the promote and access a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a repeatable pipeline of projects.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, focusing on those with a proven track record in managing life science assets.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor focused on properties near research universities and hospitals, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the UK Golden Triangle life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to share in the promote.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a specialized operator at the GP level, providing co-GP or JV equity to leverage their expertise.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from their expertise.

Co-GP / Platform:All claims are unsupported by the unreadable source.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor focused on biomanufacturing or biotech incubators to share in the promote and benefit from a growing pipeline of tenants.

Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to share in the promote.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from the sector's growth.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator involved in the development of new facilities or technologies, sharing in the promote and aligning interests.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a repeatable pipeline of deals.

Co-GP / Platform:A family office could deploy into the San Francisco life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline of leasing opportunities.

Co-GP / Platform:A family office could deploy into the San Diego life science market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a repeatable pipeline of high-quality assets.

Co-GP / Platform:A family office could deploy into the Raleigh-Durham life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from the area's strong growth trajectory.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of developments.

Co-GP / Platform:A family office could deploy into the Boston-Cambridge life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into this market by partnering with established life sciences operators at the GP level to share in the promote and benefit from the sector's growth.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level, focusing on those developing specialized lab spaces in key markets like Boston-Cambridge or New York.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline of developments.

Co-GP / Platform:A family office could deploy into this market by partnering with operators like The Silverman Group or DEVCO at the GP level to share in the promote and access a pipeline of life sciences projects.